The mechanistic classification of addictive drugs
- PMID: 17105338
- PMCID: PMC1635740
- DOI: 10.1371/journal.pmed.0030437
The mechanistic classification of addictive drugs
Abstract
The authors review recent research on the molecular mechanisms of addiction and propose a new classification for addictive drugs.
Conflict of interest statement
Figures
References
-
- Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci. 2005;8:1445–1449. - PubMed
-
- Pierce RC, Kumaresan V. The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev. 2006;30:215–238. - PubMed
-
- Berridge KC, Robinson TE. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 1998;28:309–369. - PubMed
-
- Bechara A, Nader K, van der Kooy D. A two-separate-motivational-systems hypothesis of opioid addiction. Pharmacol Biochem Behav. 1998;59:1–17. - PubMed
-
- Laviolette SR, van der Kooy D. Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol Psychiatry. 2003;8:50–59. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
